<?xml version="1.0" encoding="UTF-8"?>
<p>The interpretation of the comparison between placebo-controlled single- and multiple-dose studies is in accordance with previous publications that also show higher rates for TEAEs after multiple doses in active and placebo groups and also conclude that especially multiple-dose treatment can reveal compound-specific AE profiles [
 <xref rid="b11" ref-type="bibr">11</xref>]. 
</p>
